Hemispherx Biopharma, Inc. (NYSEMKT:HEB) announced on 9 December that it has received a new research report (dated December 5, 2014) from researchers at Howard University, Washington DC. The report describes a study in which Ampligen® (Poly I : Poly C12U) strongly inhibited the Ebola minigenome in the human embryonic kidney cell system. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) in last trading activity increased 4.55% to close at $0.23. Company weekly performance is -8.00% while its quarterly performance stands at -23.33%. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) is -58.18% away from its 52 week high.
According to WCCFTech, Advanced Micro Devices, Inc. (NYSE:AMD) and NVIDIA Corporation (NASDAQ:NVDA) are facing delays in the delivery of next-generation 20nm and 16nm GPUs, respectively. With limited capacity for GPUs, both companies have been forced to settle with other configurations. On last trading day Advanced Micro Devices, Inc. (NYSE:AMD) remains unchanged to close at $2.65. Its volatility for the week is 3.00% while volatility for the month is 3.91%. AMD’s sales growth for past 5 years was -1.80% and its EPS growth for past 5 years was 51.30%. Advanced Micro Devices, Inc. (NYSE:AMD) monthly performance is -6.36%.
Intralinks Holdings (NYSE:IL) EVP Jose Almandoz sold 4,783 shares of the stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $10.65, for a total value of $50,938.95. On last trading day IntraLinks Holdings, Inc. (NYSE:IL) increased 2.01% to close at $11.67. Its volatility for the week is 2.80% while volatility for the month is 3.32%. IL’s sales growth for past 5 years was 10.30% and its EPS growth for past 5 years was 9.50%. IntraLinks Holdings, Inc. (NYSE:IL) monthly performance is 5.90%.
Coronado Biosciences, Inc. (NASDAQ:CNDO) reports the closing on December 17, 2014 of the initial public offering of CB Pharma Acquisition Corp. (NASDAQ: CNLMU) (“CB Pharma”). CB Pharma is a Cayman Islands exempted company formed as a blank check company for the purpose of entering into a business combination with one or more businesses or entities, with a current focus in the specialty pharma and generic drug industries, among others. Coronado Biosciences, Inc. (NASDAQ:CNDO) has 26.70% insider ownership while its institutional ownership stands at 17.70%. In last trading activity company’s stock closed at $2.22.
Shares of Liquidity Services Inc. (NASDAQ:LQDT) have received an average rating of “Hold” from the eight analysts that are presently covering the stock, Stock Ratings Network.com reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $15.48. On Friday shares of Liquidity Services, Inc. (NASDAQ:LQDT) closed at $8.27. Company’s sales growth for last 5 years was 17.70%.